�鶹��ý

Prof. Adah Almutairi is a Professor of Pharmaceutical Chemistry; affiliate faculty in the departments of Bioengineering and NanoEngineering; and Director of the Center for Excellence in Nanomedicine and Engineering in the Institute of Engineering in Medicine. Professor Almutairi is a 2016 Kavli Fellow and has received numerous honors and awards such as the  in 2009 for her work on “Chemically Amplified Response Strategies for Medical Sciences”

Prof. Almutairi holds over ten US and international patents, two of which are licensed to pharmaceutical industries. Her academic contributions throughout her career to  are listed below:

• Introduced the first polymeric  to release drug in response to Concentrations of hydrogen peroxide characteristic of inflammation.
• Developed the first near infrared-degradable polymer, which enables Precise remotely controlled delivery of molecules.
• Created an activatable MRI agent with unprecedented contrast between “on” and “off” states.
• Designed a polymeric nanoparticle that enables delivery to the cytosol by rapid degradation upon exposure to mild acid.

Capsule Bio:

Professor Adah Almutairi has been a faculty member at the University of California, San Diego since 2008.  She is the director of �鶹��ý's , a rapidly expanding interdisciplinary research collaborative team developing tools for the future of biology and medicine. Her primary appointment is in the , and she is a member of the departments of  and .  She came to �鶹��ý from UC Berkeley, where she worked with Professor  to develop several nanoprobes for in vivo imaging.  Prior to that, she completed her PhD in Materials Chemistry at UC Riverside on electron delocalization and molecular structure, in which she developed a novel polymer for electromechanical actuation.